News
On April 11-14, 2024, Nanjing Sunway Biomedical Technology Co., Ltd. (hereinafter referred to as "Sunway Biology") was unveiled at the 89th China International Medical Devices (Spring) Expo (hereinafter referred to as "CMEF") ".
2024
04-23
On February 27, 2024, the white blood cell filter blood transfusion equipment and white blood cell filter products independently developed by Shuangwei Biology officially passed MDR certification and obtained MDR CE certificate issued by TUV Nande. More stringent access standards MDR CE comprehensive upgrade.
2024
02-27
Sino-Lao friendship "blood" connected
Since the "marriage" with the Lao National Red Cross Blood Center (hereinafter referred to as the "Blood Center"), the blood transfusion technology from Nanjing, Jiangsu Province has begun a special journey of life support. The messenger in the meantime is the technology of blood filtration to remove white blood cells and the technology of blood preparation.
2023
10-18
Innovation, sustainable development! With the fireworks, Nanjing Sunway Biomedical Technology Co., Ltd. "blood riboflavin pathogen inactivation product research and development and industrialization project" officially entered a new stage.
2023
08-18
Shuangwei Biology was awarded the National Specialized Special New "Little Giant" Enterprise
Recently, according to the unified deployment of the Ministry of Industry and Information Technology, the Jiangsu Provincial Department of Industry and Information Technology issued the "Announcement on the Fifth Batch of Specialized and Special New" Little Giant "Enterprises in Jiangsu Province and the Second Batch of Specialized and Special New" Little Giant "Reviewed and Passed the List of Enterprises". After strict review, Nanjing Shuangwei Biomedical Technology Co., Ltd. (hereinafter referred to as "Shuangwei Biology") relies on its leading strength in the field of safe blood transfusion, selected in the fifth batch of national specialized new "small giant" enterprises.
2023
08-02
With the process of China's aging population, the number of patients with benign prostatic hyperplasia is also increasing year by year. The expanded surgical treatment of prostate-related diseases has become an important measure for the benefit of the people. In order to promote the construction of urology and improve the operation technology of expanded surgery, the "salon exchange meeting of prostate expansion surgery" sponsored by Nanjing Shuangwei biology was held in Shanghai on July 20, 2023.
2023
08-02
Asia/Europe
Jasmine Mao
Africa/South America
Bonnie Wang
Nanjing Sunway Biomedical Technology Co., Ltd.
All rights reserved©2024 Nanjing Shuangwei Biomedical Technology Co., Ltd.
Powered by：www.300.cn Nanjing
Business License